FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1149432009: Raltegravir potassium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4555722016 Raltegravir potassium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4555723014 Raltegravir potassium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Raltegravir potassium Is a Integrase strand transfer inhibitor true Inferred relationship Some
Raltegravir potassium Is a Pyrrolidine true Inferred relationship Some
Raltegravir potassium This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Integrase strand transfer inhibitor (disposition) true Inferred relationship Some
Raltegravir potassium This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Raltegravir (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely raltegravir (as raltegravir potassium) 400 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Raltegravir potassium Inferred relationship Some 1
Raltegravir (as raltegravir potassium) 600 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Raltegravir potassium Inferred relationship Some 1
Product containing precisely raltegravir (as raltegravir potassium) 100 milligram/1 each conventional release chewable tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Raltegravir potassium Inferred relationship Some 1
Raltegravir (as raltegravir potassium) 25 mg chewable tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Raltegravir potassium Inferred relationship Some 1
Raltegravir (as raltegravir potassium) 100 mg granules for oral suspension sachet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Raltegravir potassium Inferred relationship Some 1

This concept is not in any reference sets

Back to Start